4.8 Article

Total synthesis and study of 6-deoxyerythronolide B by late-stage C-H oxidation

期刊

NATURE CHEMISTRY
卷 1, 期 7, 页码 547-551

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/NCHEM.351

关键词

-

资金

  1. National Institutes of Health/National Institute of General Medicine [GM076153]
  2. Eli Lilly
  3. Bristol-Myers Squibb
  4. Pfizer
  5. Amgen
  6. R. C. Fuson graduate fellowship
  7. Roche Excellence in Chemistry Award

向作者/读者索取更多资源

Among the frontier challenges in chemistry in the twenty-first century are the interconnected goals of increasing synthetic efficiency and diversity in the construction of complex molecules. Oxidation reactions of C-H bonds, particularly when applied at late stages of complex molecule syntheses, hold special promise for achieving both these goals. Here we report a late-stage C-H oxidation strategy in the total synthesis of 6-deoxyerythronolide B (6-dEB), the aglycone precursor to the erythromycin antibiotics. An advanced intermediate is cyclized to give the 14-membered macrocyclic core of 6-dEB using a late-stage (step 19 of 22) C-H oxidative macrolactonization reaction that proceeds with high regio-, chemo-and diastereoselectivity (>40:1). A chelate-controlled model for macrolactonization predicted the stereochemical outcome of C-O bond formation and guided the discovery of conditions for synthesizing the first diastereomeric 13-epi-6-dEB precursor. Overall, this C-H oxidation strategy affords a highly efficient and stereochemically versatile synthesis of the erythromycin core.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据